References
- Baum JK, Bookstein J J. Holtz F, et al. Possible association between benign hepatomas and oral contraceptives. Lancet 1973: 2(Oct 27): 926–9
- Christopherson WM, Mays ET. Liver tumors and contraceptive steroids: experience with the first one hundred registry patients. J Natl Cancer Inst 1977: 58(2): 167–71
- Edmondson HA, Reynolds TB, Henderson B, et al. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 1977: 86(2): 180–2
- Neuberger J, Portmann B. Nonnerley HB, et al. Oral-contraceptlve-assoclated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet 1980: 1(8163): 273–6
- Shar SR. Rew MC. Oral contraceptives and hepatocellular carcinoma. Cancer 1982: 49(2): 407–10
- Scott LD, Katz AR, Duke JH, et al. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA 1984: 251(11): 1461–3
- Nime F, Pickren JW, Vana J, et al. The histology of liver tumors In oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer 1979: 44(4): 1481–9
- Steinbrecher UP, Lisbona R, Huang SN, et al. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 1981: 26(11): 1045–50